Top News

Jul 11, 2016
By BioPharm International Editors
Patheon launches initial public offering to repay outstanding notes and expenses.
Jul 08, 2016
A Federal Circuit court ruled biosimilar makers must wait 180 days after receiving FDA approval before bringing drugs to market.
Jul 06, 2016
By BioPharm International Editors
The agency says, for now, it’s business as usual.
Jul 05, 2016
By BioPharm International Editors
The acquisition will give Bristol-Myers Squibb full rights to Cormorant’s HuMax-IL8 antibody program.
Jun 28, 2016
Antibodies to dengue may either confer protective immunity to the Zika virus or enhance disease severity in secondary, related infections such as Zika.
Jun 27, 2016
By BioPharm International Editors
The companies agree to exchange ownership of Sanofi’s animal health and Boehringer Ingelheim’s consumer healthcare businesses.
Jun 24, 2016
In the wake of Britain’s decision to exit the EU, pharma companies face uncertainty.
Jun 21, 2016
A research team associated with Dr. Carl June announces it has discovered a way to engineer a patient’s own immune cells to recognize cancer-specific glycoantigens on tumor cells.
Jun 17, 2016
The first-ever use of CRISPR in humans will be evaluated by the National Institutes of Health during a meeting from June 21–22, 2016.
Jun 17, 2016
In a lawsuit against Celltrion, Janssen alleges the GE subsidiary infringed one of Janssen’s patents covering the method of making the cell-culture media that HyClone later supplied to Celltrion.
lorem ipsum